Olanzapine LAI: Long-Acting Injection Overview
16 Questions
0 Views

Olanzapine LAI: Long-Acting Injection Overview

Created by
@ninusu

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Olanzapine pamoate is well soluble in water.

False

The half-life of olanzapine long-acting injection (LAI) is approximately 30 days.

True

Deltoid injection is the preferred route for administering olanzapine LAI.

False

Post-injection syndrome occurs more frequently than 1% of injections.

<p>False</p> Signup and view all the answers

When switching from oral therapy to olanzapine LAI, previous antipsychotics must be immediately stopped.

<p>False</p> Signup and view all the answers

The loading dose of olanzapine LAI for an equivalent of 10mg/day is 210mg every 4 weeks.

<p>False</p> Signup and view all the answers

Efficacy of olanzapine LAI is typically observed within 4 days following injection.

<p>False</p> Signup and view all the answers

Switching from risperidone LAI to olanzapine should occur immediately after the last risperidone injection.

<p>False</p> Signup and view all the answers

Patients must be observed in a healthcare facility for at least 4 hours after receiving olanzapine LAI injections.

<p>False</p> Signup and view all the answers

It is safe for patients to drive or operate machinery on the same day of their olanzapine LAI injection.

<p>False</p> Signup and view all the answers

Monitoring procedures for olanzapine LAI injections can be relaxed in countries where the incidence of adverse reactions is very low.

<p>True</p> Signup and view all the answers

Prior to leaving the facility, it is necessary for a patient to show signs of overdose for monitoring to be considered complete.

<p>False</p> Signup and view all the answers

Risk factors for post-injection syndrome include male gender and prior injection site adverse effects.

<p>True</p> Signup and view all the answers

Reactions after olanzapine LAI injections can occur up to 12 hours post-injection.

<p>True</p> Signup and view all the answers

Patients are advised to monitor for signs of overdose for only the first hour post-injection.

<p>False</p> Signup and view all the answers

A large study found a significant correlation between injection-related syndrome and certain risk factors.

<p>True</p> Signup and view all the answers

Study Notes

Olanzapine LAI: Long-Acting Injection

  • Olanzapine pamoate, an injectable form of olanzapine, is poorly soluble in water.
  • It provides a sustained release of olanzapine after intramuscular injection.
  • Peak plasma levels are reached within 2-4 days, and efficacy is seen within 3 days.
  • Gluteal injection is preferred over deltoid injection due to greater efficacy.
  • The half-life of olanzapine LAI is approximately 30 days.
  • It is typically administered every 4 weeks, but frequency can be adjusted based on the dose.
  • While not directly compared in RCTs, naturalistic data suggest similar effectiveness to paliperidone LAI.

Dosing Schedules

  • There are specific loading and maintenance doses depending on the equivalent oral olanzapine dosage.

Switching

  • Switching to olanzapine LAI is often possible, ideally after an oral trial.
  • Direct switching from other LAIs (except risperidone) can occur on the same day as the previous LAI would have been administered.
  • Switching from oral therapy is possible, but prior medications should be reduced gradually.
  • When switching from risperidone LAI, initiating olanzapine 2 weeks after the last risperidone injection is recommended due to risperidone's longer half-life.

Post-Injection Syndrome

  • Post-injection syndrome can occur due to inadvertent intravasation, leading to high olanzapine plasma levels.
  • Symptoms include delirium and somnolence, typically appearing within an hour of injection.
  • The incidence is low, less than 0.1% of injections.
  • Risk factors include previous injection site adverse effects, male gender, and higher doses.
  • Despite its rarity, post-injection syndrome can happen even after prior safe use of olanzapine LAI.

Monitoring Procedures

  • Patients must be observed for at least 3 hours post-injection by qualified personnel.
  • Before leaving the facility, they should be alert, oriented, and show no signs of overdose.
  • The observation period can be extended if clinically appropriate.
  • Patients should continue monitoring for overdose symptoms throughout the day and seek help if needed.
  • It's advised to avoid driving or operating machinery on the day of injection.

Important Considerations

  • Post-injection reactions are rare but often manifest within an hour.
  • Some countries have shortened the observation period to 2 hours due to fewer reported cases after that timeframe.
  • While post-injection syndrome is rare, prior injection site problems, male gender, and high dose administration may increase the risk.

Conclusion

  • Olanzapine LAI may be associated with post-injection reactions and syndrome.
  • Strict monitoring procedures are crucial.
  • The post-injection syndrome risk may hinder the popularity of the medication, but some individuals continue treatment despite episodes.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

This quiz covers the essentials of Olanzapine LAI, including its administration, peak levels, and dosing schedules. Learn about the advantages of gluteal injections, switching protocols, and how it compares to paliperidone LAI. Test your understanding of the long-acting injectable form of olanzapine and its clinical implications.

More Like This

Zyprexa (Olanzapine) Flashcards
10 questions
Olanzapine Flashcards
4 questions
Use Quizgecko on...
Browser
Browser